Literature DB >> 12592240

Ethnic differences at risk for gestational trophoblastic disease in New Mexico: A 25-year population-based study.

Harriet O Smith1, Robert D Hilgers, Edward J Bedrick, Clifford R Qualls, Charles L Wiggins, William F Rayburn, Alan G Waxman, Nicole D Stephens, Laurence W Cole, Marian Swanson, Charles R Key.   

Abstract

OBJECTIVE: The purpose of this study was to compare gestational trophoblastic disease incidence rates with the use of population-based data. STUDY
DESIGN: All incident cases between 1973 and 1997 and live birth, pregnancy, and women at risk were tabulated with the use of data that were derived from the New Mexico Tumor Registry and Vital Records and Health Statistics Annual Reports. Statistical methods included trends analyses, odds ratios, and Poisson regression.
RESULTS: Of 939 total cases, 312 non-Hispanic white women, 399 Hispanic white women, 201 American Indian women, and 27 other women were affected. Age-adjusted incidence rates were significantly higher for American Indian women (11.16%) compared with non-Hispanic (3.57%) or Hispanic white women (5.32%); the probability value was <.001. When live birth (1:438 women) and pregnancy (1:486 women) denominators were considered, American Indian women alone were at increased risk, and the ratio increased by 56% over 25 years. American Indian women were also at increased risk for partial mole (relative risk, 4.03; 95% CI, 2.57-6.31), invasive mole (relative risk, 26.7; 95% CI, 7.81-93.14), and choriocarcinoma (relative risk, 6.29; 95% CI, 1.81-22.66) variants.
CONCLUSION: American Indians are at increased risk relative to the other predominant ethnic groups in New Mexico. Age-adjusted standardization provided a reproducible measurement that may be applicable across other registries.

Entities:  

Mesh:

Year:  2003        PMID: 12592240     DOI: 10.1067/mob.2003.39

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Diagnosis of hydatidiform moles by polymorphic deletion probe fluorescence in situ hybridization.

Authors:  Sarah Chiang; Ladan Fazlollahi; Anhthu Nguyen; Rebecca A Betensky; Drucilla J Roberts; A John Iafrate
Journal:  J Mol Diagn       Date:  2011-04-29       Impact factor: 5.568

Review 2.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

3.  Incidence of gestational trophoblastic disease in South Korea: a longitudinal, population-based study.

Authors:  Jin-Sung Yuk; Jong Chul Baek; Ji Eun Park; Hyen Chul Jo; Ji Kwon Park; In Ae Cho
Journal:  PeerJ       Date:  2019-02-20       Impact factor: 2.984

4.  Urinary Metabolites Altered during the Third Trimester in Pregnancies Complicated by Gestational Diabetes Mellitus: Relationship with Potential Upcoming Metabolic Disorders.

Authors:  Yamilé López-Hernández; Ana Sofía Herrera-Van Oostdam; Juan Carlos Toro-Ortiz; Jesús Adrián López; Mariana Salgado-Bustamante; Michael Murgu; Lourdes Mariela Torres-Torres
Journal:  Int J Mol Sci       Date:  2019-03-08       Impact factor: 5.923

5.  Dysregulation of Placental Functions and Immune Pathways in Complete Hydatidiform Moles.

Authors:  Jennifer R King; Melissa L Wilson; Szabolcs Hetey; Peter Kiraly; Koji Matsuo; Antonio V Castaneda; Eszter Toth; Tibor Krenacs; Petronella Hupuczi; Paulette Mhawech-Fauceglia; Andrea Balogh; Andras Szilagyi; Janos Matko; Zoltan Papp; Lynda D Roman; Victoria K Cortessis; Nandor Gabor Than
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

6.  Implementation and Monitoring of a Gestational Trophoblastic Disease Management Program in a Tertiary Hospital in Morocco: Opportunities and Challenges.

Authors:  Imane Khachani; Mohamed Hassan Alami; Rachid Bezad
Journal:  Obstet Gynecol Int       Date:  2017-04-16

7.  Decreasing incidence of registered hydatidiform moles in Denmark 1999-2014.

Authors:  Helle Lund; Mogens Vyberg; Helle Højmark Eriksen; Anni Grove; Annette Østergaard Jensen; Lone Sunde
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.